Postgraduate medicine
-
Postgraduate medicine · Nov 2024
Randomized Controlled TrialPentoxifylline improves anemia through its novel effect on hypoxia-inducible factor-2 alpha in hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial.
This randomized, double-blind, placebo-controlled clinical trial aimed to prospectively examine the effect of pentoxifylline (PTX) on hypoxia-inducible factor-2 alpha (HIF-2α) and its role in controlling anemia in hemodialysis (HD) patients. ⋯ Clinicaltrials.gov, February 2023, registry number: NCT05708248.